Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
jueves, octubre 08
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
LifeStance Health Group Inc
LFST
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$12.15
0.04
0.33%
Últ. Act.: Oct 8, 8:05 AM
$12.15
0.04
0.33%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
LifeStance Health Gr Financials
LifeStance Health Gr (LFST) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
LifeStance Health Gr Sees Q3 Sales $420.000M-$440.000M vs $418.474M Est
LifeStance Health Gr (NASDAQ:LFST) sees Q3 sales of $420.000 million-$440.000 million vs $418.474 million analyst estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B Est
LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.640 billion-$1.680 billion to $1.685 billion-$1.725 billion vs $1.665 billion estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Q2 EPS $0.06 Beats $0.04 Estimate, Sales $435.354M Beat $414.577M Estimate
LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 700 percent increase over losses of $(0.01) per share from
Benzinga Newsdesk
PRO
LifeStance Health Gr Sees Q2 Sales $405.000M-$425.000M vs $401.519M Est
LifeStance Health Gr (NASDAQ:LFST) sees Q2 sales of $405.000 million-$425.000 million vs $401.519 million analyst estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.615B-$1.655B to $1.640B-$1.680B vs $1.636B Est
LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.615 billion-$1.655 billion to $1.640 billion-$1.680 billion vs $1.636 billion estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Q1 EPS $0.04 Beats $0.01 Estimate, Sales $403.476M Beat $387.367M Estimate
LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. The company reported quarterly sales of $403.476 million which beat
Benzinga Newsdesk
